Companies: 10,795·Total market cap: $144.5T
Accelerate Diagnostics, Inc.

Accelerate Diagnostics, Inc.

AXDXNASDAQHealthcare
$0.03
+$0.00(+0.00%)
Market Cap$859918
P/E Ratio
52W High$2.09
52W Low$0.01

Accelerate Diagnostics, Inc.(AXDX)· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · AXDX · 截至 2026-06-09

财务报表

Revenue · Gross Profit · Net Income
Breakdown2024-122023-122022-122021-122020-12
Revenue
Revenue$11.70M$12.06M$12.75M$11.78M$11.16M
Cost of Revenue$8.99M$9.51M$9.45M$12.16M$6.71M
Gross Profit$2.70M$2.55M$3.30M($0.38M)$4.46M
Gross Margin %(computed)23.12%21.15%25.90%-3.23%39.94%
Operating Expenses
R&D Expenses$16.69M$25.35M$26.91M$21.94M$21.25M
G&A Expenses$0.00M$0.00M$0.00M$0.00M$0.00M
Total Operating Expenses$38.01M$56.58M$66.11M$71.18M$68.16M
Operating Income($35.31M)($54.03M)($62.80M)($71.56M)($63.70M)
Operating Margin %(computed)-301.85%-448.03%-492.51%-607.37%-570.53%
Interest Income$0.70M$1.12M$0.55M$0.09M$0.85M
Interest Expense$13.12M$7.74M$3.77M$15.54M$15.55M
Income Before Tax($50.11M)($60.77M)($62.57M)($77.66M)($78.20M)
Income Tax Expense($0.07M)$0.85M($0.08M)$0.04M$0.01M
Net Income($50.05M)($61.62M)($62.49M)($77.70M)($78.21M)
Net Margin %(computed)-427.81%-510.97%-490.06%-659.50%-700.47%
Per Share & EBITDA
EPS (Basic)$-2.15$-4.94$-7.61$-12.59$-13.96
Wtd Avg Shares23.30M12.48M8.22M6.17M5.60M
EBITDA($33.57M)($49.77M)($55.80M)($59.59M)($59.66M)
EBITDA Margin %(computed)-287.00%-412.73%-437.57%-505.81%-534.31%

数据来源:Financial Modeling Prep · 最后更新:2026-06-09 · USD · M

深入了解Accelerate Diagnostics, Inc.

关于Accelerate Diagnostics, Inc.(AXDX)损益表

Accelerate Diagnostics, Inc.(AXDX)损益表数据来源于SEC Form 10-K及10-Q申报文件。2024财年,AXDX实现营收$0.01B,毛利润$0.00B(毛利率23.12%),净利润($0.05B)(净利率-427.81%)。

常见问题

AXDX · 4 问

Accelerate Diagnostics, Inc.(AXDX)2024财年营收为$0.01B,同比down3.0%。

AXDX revenueAXDX salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09